These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3275769)

  • 1. Immunosuppressive therapy of HBsAg-positive chronic active hepatitis in childhood: a multicentric retrospective study on 139 patients.
    Giusti G; Piccinino F; Sagnelli E; Ruggiero G; Galanti B; Gallo C
    J Pediatr Gastroenterol Nutr; 1988; 7(1):17-21. PubMed ID: 3275769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive therapy in chronic active hepatitis (CAH). A multicentric retrospective study on 867 patients. A report from a study group for CAH of the Italian Association for the study of the liver.
    Giusti G; Piccinino F; Galanti B; Sagnelli E; Ruggiero G; Gallo C
    Hepatogastroenterology; 1984 Feb; 31(1):24-9. PubMed ID: 6698485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of chronic active hepatitis (CAH): a retrospective review of 130 patients.
    Giusti G; Ruggiero G; Galanti B; Piccinino F; Russo M; Galante D; Sagnelli E; Utili R; Pasquale G; Nardiello S; Aloisio V
    Hepatogastroenterology; 1981 Oct; 28(5):245-9. PubMed ID: 7047337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive treatment of chronic HBsAg-positive hepatitis in childhood.
    Tolentino P; Jannuzzi C; Giacchino R
    Infection; 1983; 11(5):255-9. PubMed ID: 6642677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inefficacy of immunosuppressive treatment in HBSAg-positive, delta-negative, moderate chronic active hepatitis in children.
    Vajro P; Orso G; D'Antonio A; Greco L; Fontanella A; Loffredo G; Oggero V; Buffolano W
    J Pediatr Gastroenterol Nutr; 1985 Feb; 4(1):26-31. PubMed ID: 3884766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive therapy in chronic liver disease.
    Sherlock S
    Minerva Med; 1978 Aug; 69(38):2605-9. PubMed ID: 714260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of HBsAg-positive chronic active hepatitis with corticosteroids and/or azathioprine. A prospective study.
    Manzillo G; Piccinino F; Sagnelli E; Izzo CM; Pasquale G; Maio G; Filippini P; Felaco FM
    Ric Clin Lab; 1983; 13(2):261-8. PubMed ID: 6622929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunosuppressive treatment of HBs-antigen positive and negative chronic-active hepatitis (author's transl)].
    Meyer KH
    Dtsch Med Wochenschr; 1978 May; 103(21):887-92. PubMed ID: 648378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis.
    Lam KC; Lai CL; Trepo C; Wu PC
    N Engl J Med; 1981 Feb; 304(7):380-6. PubMed ID: 7005678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunosuppressive treatment of patients with chronic active HBsAg positive hepatitis].
    Tanno H; Fay O; Roldán L; Vorovioff J
    Acta Gastroenterol Latinoam; 1982; 12(4):323-32. PubMed ID: 7185230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of hepatitis B surface and core antigens during immunosuppressive treatment of HBsAg-positive chronic active hepatitis.
    Sagnelli E; Manzillo G; Maio G; Pasquale G; Felaco FM; Filippini P; Izzo CM; Piccinino F
    Lancet; 1980 Aug; 2(8191):395-7. PubMed ID: 6105519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of corticosteroids on suppressor-cell activity in "autoimmune" and viral chronic active hepatitis.
    Nouri-Aria KT; Hegarty JE; Alexander GJ; Eddleston AL; Williams R
    N Engl J Med; 1982 Nov; 307(21):1301-4. PubMed ID: 6215581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose corticosteroid therapy after multiple relapses of severe HBsAg-negative chronic active hepatitis.
    Czaja AJ
    Hepatology; 1990 Jun; 11(6):1044-9. PubMed ID: 2365282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled trials of immunosuppressive therapy in hepatitis.
    Stern RB; Williams R
    Postgrad Med J; 1974 Jun; 50(584):392-4. PubMed ID: 4377173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discontinuation of immunosuppressive therapy in hepatitis B surface antigen-positive chronic hepatitis: effect on viral replication and on liver cell damage.
    Hess G; Manns M; Hütteroth TH; Meyer zum Büschenfelde KH
    Digestion; 1987; 36(1):47-54. PubMed ID: 3556804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrahepatic malignancy following long-term immunosuppressive therapy of severe hepatitis B surface antigen-negative chronic active hepatitis.
    Wang KK; Czaja AJ; Beaver SJ; Go VL
    Hepatology; 1989 Jul; 10(1):39-43. PubMed ID: 2737603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B.
    Scullard GH; Smith CI; Merigan TC; Robinson WS; Gregory PB
    Gastroenterology; 1981 Dec; 81(6):987-91. PubMed ID: 7286593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigen.
    Schalm SW; Summerskill WH; Gitnick GL; Elveback LR
    Gut; 1976 Oct; 17(10):781-6. PubMed ID: 793956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current aspects of the therapy of chronic hepatitis (a review of the literature)].
    Cherednichenko TV
    Vopr Okhr Materin Det; 1979 Nov; 24(11):43-8. PubMed ID: 388858
    [No Abstract]   [Full Text] [Related]  

  • 20. Different mechanisms responsible for in vitro cell-mediated cytotoxicity to autologous hepatocytes in children with autoimmune and HBsAg-positive chronic liver disease.
    Mondelli M; Mieli-Vergani G; Bortolotti F; Cadrobbi P; Portmann B; Alberti A; Realdi G; Eddleston AL; Mowat AP
    J Pediatr; 1985 Jun; 106(6):899-906. PubMed ID: 3998945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.